
matdesign24/iStock via Getty Images
- Inspire Medical Systems (NYSE:INSP) is reaffirming updated 2025 financial guidance it made earlier this month following its Q2 results.
- At that time, the maker of a sleep apnea treatment implant significantly cut its revenue and EPS expectations citing slower than